Aadi Bioscience, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
QVT FINANCIAL LP | 05/15/2025 | 4.52 M | $7.64 M | 95.17% | 11.39% |
ORBIMED ADVISORS LLC | 05/15/2025 | 4.17 M | $7.42 M | 100.00% | 10.51% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 3.70 M | $6.59 M | 100.00% | 9.33% |
ACUTA CAPITAL PARTNERS, LLC | 05/15/2025 | 3.41 M | $6.07 M | 84.41% | 8.60% |
AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 2.85 M | $5.07 M | 0.00% | 7.19% |
SIREN, L.L.C. | 05/23/2025 | 2.08 M | $3.71 M | 100.00% | 5.25% |
YU FAN | 05/15/2025 | 2.07 M | $3.68 M | 100.00% | 5.22% |
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 1.89 M | $3.36 M | -9.99% | 4.77% |
05/19/2025 | 1.14 M | $2.03 M | -0.67% | 2.87% | |
ALLY BRIDGE GROUP (NY) LLC | 05/15/2025 | 817.94 K | $1.46 M | 0.00% | 2.06% |
VANGUARD GROUP INC | 05/09/2025 | 765.99 K | $1.36 M | 0.00% | 1.93% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 462.12 K | $822.58 K | 1.34% | 1.17% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 315.28 K | $561.21 K | 173.21% | 0.80% |
04/30/2025 | 241.40 K | $429.70 K | -45.50% | 0.61% | |
BLACKROCK, INC. | 05/02/2025 | 241.25 K | $429.42 K | -1.08% | 0.61% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 235.84 K | $419.91 K | 8.54% | 0.59% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 107.52 K | $191.82 K | 202.06% | 0.27% |
CITADEL ADVISORS LLC | 05/15/2025 | 97.31 K | $173.22 K | 56.87% | 0.25% |
NORTHERN TRUST CORP | 05/13/2025 | 86.32 K | $153.66 K | -5.30% | 0.22% |
STATE STREET CORP | 05/15/2025 | 68.74 K | $122.35 K | 0.00% | 0.17% |
MORGAN STANLEY | 05/15/2025 | 64.24 K | $114.34 K | 403.39% | 0.16% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 52.49 K | $93.43 K | -8.74% | 0.13% |
STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 46.70 K | $83.12 K | 100.00% | 0.12% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 44.82 K | $79.79 K | -74.24% | 0.11% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 43.16 K | $76.82 K | -37.05% | 0.11% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 40.97 K | $72.93 K | -33.58% | 0.10% |
SG AMERICAS SECURITIES, LLC | 04/15/2025 | 36.77 K | $65.00 K | 100.00% | 0.09% |
UBS GROUP AG | 05/13/2025 | 35.57 K | $63.31 K | -39.89% | 0.09% |
ABG INNOVATION CAPITAL PARTNERS III GP LTD | 05/15/2025 | 26.67 K | $47.47 K | 0.00% | 0.07% |
JANE STREET GROUP, LLC | 05/19/2025 | 26.66 K | $47.46 K | 100.00% | 0.07% |
PRUDENTIAL FINANCIAL INC | 05/13/2025 | 21.80 K | $38.80 K | -17.42% | 0.06% |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 10.20 K | $18.15 K | -20.94% | 0.03% |
US BANCORP \DE\ | 05/08/2025 | 3.33 K | $5.93 K | 0.00% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 3.10 K | $5.52 K | 3.85% | 0.01% |
CITADEL ADVISORS LLC | 05/15/2025 | 2.60 K | $4.63 K | -82.67% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.56 K | $4.55 K | 517.15% | 0.01% |
CITADEL ADVISORS LLC | 05/15/2025 | 2.10 K | $3.74 K | -32.26% | 0.01% |
JPMORGAN CHASE & CO | 05/12/2025 | 1.76 K | $3.14 K | 19.22% | 0.00% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 1.51 K | $2.69 K | 0.00% | 0.00% |
BARTLETT & CO. WEALTH MANAGEMENT LLC | 04/24/2025 | 1.33 K | $2.37 K | 0.00% | 0.00% |
FEDERATED HERMES, INC. | 05/08/2025 | 930 | $1.66 K | -80.31% | 0.00% |
SEMMAX FINANCIAL ADVISORS INC. | 05/16/2025 | 297 | $144.93 K | 100.00% | 0.00% |
TD WATERHOUSE CANADA INC. | 05/09/2025 | 232 | $394 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 180 | $320 | 4.65% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 160 | $285 | -18.78% | 0.00% |
CITIGROUP INC | 05/12/2025 | 75 | $134 | 0.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 33 | $59 | -94.50% | 0.00% |
05/02/2025 | 20 | $36 | -95.33% | 0.00% | |
SVB WEALTH LLC | 05/14/2025 | 16 | $28 | 100.00% | 0.00% |
PARALLEL ADVISORS, LLC | 04/08/2025 | 8 | $14 | 0.00% | 0.00% |
Aadi Bioscience, Inc. institutional Ownership - FAQ's
During the previous two years, 61 institutional investors and hedge funds held shares of Aadi Bioscience, Inc.. The most heavily invested institutionals were:
QVT Financial LP: 4.52 M
ORBIMED ADVISORS LLC: 4.17 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 3.7 M
ACUTA CAPITAL PARTNERS, LLC: 3.41 M
Avoro Capital Advisors LLC: 2.85 M
Siren, L.L.C.: 2.08 M
74.99% of Aadi Bioscience, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.20 M shares in the last 24 months. This purchase volume represents approximately $59.85 M in transactions.